143 related articles for article (PubMed ID: 19061586)
1. Management of allergy to heparins in postoperative care: subcutaneous allergy and intravenous tolerance.
Seitz CS; Brocker EB; Trautmann A
Dermatol Online J; 2008 Sep; 14(9):4. PubMed ID: 19061586
[TBL] [Abstract][Full Text] [Related]
2. Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial.
de Valk HW; Banga JD; Wester JW; Brouwer CB; van Hessen MW; Meuwissen OJ; Hart HC; Sixma JJ; Nieuwenhuis HK
Ann Intern Med; 1995 Jul; 123(1):1-9. PubMed ID: 7539233
[TBL] [Abstract][Full Text] [Related]
3. Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans.
Ludwig RJ; Beier C; Lindhoff-Last E; Kaufmann R; Boehncke WH
Contact Dermatitis; 2003 Sep; 49(3):158-9. PubMed ID: 14678213
[No Abstract] [Full Text] [Related]
4. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study.
Grassegger A; Fritsch P; Reider N
Dermatol Surg; 2001 Jan; 27(1):47-52. PubMed ID: 11231243
[TBL] [Abstract][Full Text] [Related]
5. Eczematous plaques related to unfractionated and low-molecular-weight heparins: cross-reaction with danaparoid but not with desirudin.
Martin L; Machet L; Gironet N; Pouplard C; Gruel Y; Vaillant L
Contact Dermatitis; 2000 May; 42(5):295-6. PubMed ID: 10789857
[No Abstract] [Full Text] [Related]
6. A comparative review of the adverse effect profiles of heparins and heparinoids.
Borris LC; Lassen MR
Drug Saf; 1995 Jan; 12(1):26-31. PubMed ID: 7537967
[TBL] [Abstract][Full Text] [Related]
7. Danaparoid: a review of its use in thromboembolic and coagulation disorders.
Ibbotson T; Perry CM
Drugs; 2002; 62(15):2283-314. PubMed ID: 12381232
[TBL] [Abstract][Full Text] [Related]
8. [Delayed intracutaneous test reaction in heparin intolerance].
Wurpts G; Merk HF
Hautarzt; 2007 May; 58(5):394-6. PubMed ID: 17450341
[No Abstract] [Full Text] [Related]
9. [Use of low molecular weight heparins by dermatologists].
Maakaroun A; Gruel Y
Ann Dermatol Venereol; 2003 Apr; 130(4):473-8. PubMed ID: 12843865
[No Abstract] [Full Text] [Related]
10. Heparin allergy: delayed-type non-IgE-mediated allergic hypersensitivity to subcutaneous heparin injection.
Trautmann A; Seitz CS
Immunol Allergy Clin North Am; 2009 Aug; 29(3):469-80. PubMed ID: 19563992
[TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.
JAMA; 1998 Apr 22-29; 279(16):1265-72. PubMed ID: 9565006
[TBL] [Abstract][Full Text] [Related]
12. Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids.
Boehncke WH; Weber L; Gall H
Contact Dermatitis; 1996 Aug; 35(2):73-5. PubMed ID: 8917822
[TBL] [Abstract][Full Text] [Related]
13. Delayed-type hypersensitivity to subcutaneous heparin with tolerance of i.v. administration.
Liew G; Campbell C; Thursby P
ANZ J Surg; 2004 Nov; 74(11):1020-1. PubMed ID: 15550103
[No Abstract] [Full Text] [Related]
14. Delayed-type skin reaction to the heparin-alternative danaparoid.
Szolar-Platzer C; Aberer W; Kränke B
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):920-2. PubMed ID: 11044823
[TBL] [Abstract][Full Text] [Related]
15. [Delayed hypersensitivity to heparins and heparinoids].
Nicolie B; Bonneau JC; Le Sellin J; Gay G; Leclere JM; Drouet M
Allerg Immunol (Paris); 2002 Feb; 34(2):47-50. PubMed ID: 11933754
[TBL] [Abstract][Full Text] [Related]
16. Successful use of heparinoids in a pregnancy complicated by allergy to heparin.
Taylor AA
BJOG; 2001 Sep; 108(9):1011-2. PubMed ID: 11563455
[No Abstract] [Full Text] [Related]
17. An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran).
Magnani HN
Thromb Res; 2010 Apr; 125(4):297-302. PubMed ID: 19656552
[TBL] [Abstract][Full Text] [Related]
18. [Successful therapy of heparin-associated thrombocytopenia with a low sulfated heparinoid].
Herzog S; Rath W; Kuhn W
Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):164-6. PubMed ID: 7665065
[TBL] [Abstract][Full Text] [Related]
19. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
Gaigl Z; Pfeuffer P; Raith P; Bröcker EB; Trautmann A
Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543
[TBL] [Abstract][Full Text] [Related]
20. Eczematous plaques related to unfractionated and low-molecular-weight heparin in pregnancy: cross-reaction with danaparoid sodium.
Blickstein D; Hod M; Bar J
Blood Coagul Fibrinolysis; 2003 Dec; 14(8):765-8. PubMed ID: 14614358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
